# Relmada Therapeutics, Inc.: Form 8-K, filed Dec 22, 2021

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2021-12-22
- Accepted by EDGAR: Dec 22, 2021, 17:21 ET
- Period: 2021-12-22
- Accession: 0001213900-21-067091
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390021067091/ea152954-8k_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390021067091/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390021067091/ea152954-8k_relmada.htm

Filed Dec 22, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-067091. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
